-
12-lead ECG obtained from a 50-year old African American man with hypertension and chest pain.
-
FDA warnings for existing drugs dominate pharmaceutical news this month.
-
Serum analysis of 45 subjects for antibodies and humoral immunity over a median of 15 years showed antiviral responses ranging from 11-19 years for tetanus-diphtheria, 50 years for varicella-zoster, and up to 200 years for measles and mumps.
-
The FDA has approved a non-halogenated nasal steroid for use in pediatric patients aged 6 to 12 years and adults. Ciclesonide is a prodrug that was previously approved for adults and adolescents but was not marketed. It's to be marketed by Nycomed US Inc. as Omnaris.
-
-
Performance-enhancement supplements, also called ergogenic aids, remain popular among athletes. Up to 3 million people in the United States are believed to use anabolic-androgenic steroids (AAS). However, the profile of those using such drugs is broadening.
-
Pycky, Pycky — French Maritime Bark and Menopause, Anxious Hearts — Anxiety and CVD
-
-
An integrative approach to high blood pressure ventures into many realms, including herbal medicine. For supporting cardiovascular health and treating heart disease, hawthorn is a botanical treatment that often comes to mind.
-
The term "dementia" refers to central nervous system (CNS) pathology that makes it hard for a person to remember, learn, and communicate. It may also involve perception, emotional behavior, and cognitive skills. Usually, dementia presents as forgetfulness, but may eventually lead to disruptive behavior.
